Covance Buys Caprion Proteomics Equity Stake | GenomeWeb
NEW YORK (GenomeWeb News) – Princeton, NJ-based drug development services company Covance announced yesterday that it has purchased an undisclosed minority stake in the proteomics-based pharmaceutical services company Caprion Proteomics.
 
Under the agreement, Covance will use Caprion as its exclusive proteomic discovery provider and will act as the exclusive contract research organization distributor for Caprion’s proteomic biomarker services.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.